Presenting syndromes of human immunodeficiency virus

Mayo Clinic Proceedings

Volumn 77, Issue 10, 2002, Pages 1097-1102

  Orenstein, Robert ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; NUCLEOSIDE ANALOG; RNA DIRECTED DNA POLYMERASE INHIBITOR;

CLINICAL FEATURE; DISEASE COURSE; DRUG INDUCED DISEASE; EPIDEMIC; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPODYSTROPHY; MITOCHONDRIAL MYOPATHY; MYCOBACTERIOSIS; NEUROLOGICAL COMPLICATION; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS PNEUMONIA; SHORT SURVEY; SKIN MANIFESTATION; SYNDROME DELINEATION; TUBERCULOSIS; VIRUS INFECTION; ACUTE DISEASE; AIDS RELATED COMPLEX; CD4 LYMPHOCYTE COUNT; CHRONIC DISEASE; DIFFERENTIAL DIAGNOSIS; REVIEW; SYNDROME;

ACUTE DISEASE; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; HIV INFECTIONS; HUMANS; SYNDROME;

EID: 0036787450     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/77.10.1097     Document Type: Review

References (19)

1. Sackoff JE, Shin SS. Trends in immunologic and clinical status of newly diagnosed HIV-positive patients initiating care in the HAART era. J Acquir Immune Defic Syndr. 2001;28:270-272.
2. Dybul M, Bolan R, Condoluci D, et al. Evaluation of initial CD4+ T cell counts in individuals with newly diagnosed human immunodeficiency virus infection, by sex and race, in urban settings. J Infect Dis. 2002;185:1818-1821.
3. Couturier E, Schwoebel V, Michon C, et al. Determinants of delayed diagnosis of HIV infection in France, 1993-1995. AIDS. 1998;12:795-800.
4. Levine AM. Evaluation and management of HIV-infected women. Ann Intern Med. 2002;136:228-242.
5. Little SJ. Transmission and prevalence of HIV resistance among treatment-naïve subjects. Antivir Ther. 2000;5:33-40.
6. Bartlett JG. The 2002 Abbreviated Guide to Medical Management of HIV Infection. Baltimore, Md: Johns Hopkins University; 2002. Available at: www.hopkins-aids.edu. Accessibility verified September 9, 2002.
7. Daar ES, Little S, Pitt J, et al. Diagnosis of primary HIV-1 infection: Los Angeles County Primary HIV Infection Recruitment Network. Ann Intern Med. 2001;134:25-29.
8. Kaplan MH, Sadick N, McNutt NS, Meltzer M, Sarngadharan MG, Pahwa S. Dermatologic findings and manifestations of acquired immunodeficiency syndrome (AIDS). J Am Acad Dermatol. 1987;16(3, pt 1):485-506.
9. Friedman-Kien AE, Lafleur FL, Gendler E, et al. Herpes zoster: a possible early clinical sign for the development of acquired immunodeficiency syndrome in high-risk individuals. J Am Acad Dermatol. 1986;14:1023-1028.
10. Schwartz JJ, Myskowski PL. Molluscum contagiosum in patients with human immunodeficiency virus infection: a review of twenty-seven patients. J Am Acad Dermatol. 1992;27:583-588.
11. Obuch ML, Maurer TA, Becker B, Berger TG. Psoriasis and human immunodeficiency virus infection. J Am Acad Dermatol. 1992;27(5, pt 1):667-673.
12. Zon LI, Groopman JE. Hematologic manifestations of the human immune deficiency virus (HIV). Semin Hematol. 1988;25:208-218.
13. Kaslow RA, Phair JP, Friedman HB, et al. Infection with the human immunodeficiency virus: clinical manifestations and their relationship to immune deficiency: a report from the Multicenter AIDS Cohort study. Ann Intern Med. 1987;107:474-480.
14. Mitsuyasu R. Oncological complications of human immunodeficiency virus disease and hematologic consequences of their treatment. Clin Infect Dis. 1999;29:35-43.
15. Semba RD, Shah N, Klein RS, Mayer KH, Schuman P, Vlahov D. Human Immunodeficiency Virus Epidemiology Research Study Group. Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus-infected and -uninfected women. Clin Infect Dis. 2002;34:260-266.
16. Glatt AE, Anand A. Thrombocytopenia in patients infected with human immunodeficiency virus: treatment update. Clin Infect Dis. 1995;21:415-423.
17. Szczecb LA. Renal diseases associated with human immunodeficiency virus infection: epidemiology, clinical course, and management. Clin Infect Dis. 2001;33:115-119.
18. Weisberg LA. Neurologic abnormalities in human immunodeficiency virus infection. South Med J. 2001;94:266-275.
19. Wanke CA, Falutz JM, Shevitz A, Phair JP, Kotler DP. Clinical evaluation and management of metabolic and morphologic abnormalities associated with human immunodeficiency virus. Clin Infect Dis. 2002;34:248-259.